Drug Type Small molecule drug |
Synonyms Zabicipril, S 10211, S 9650 + [2] |
Target |
Action inhibitors |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H33ClN2O5 |
InChIKeyWCWYSBWIUQMISS-ZHQQCJAHSA-N |
CAS Registry90130-77-1 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Heart Failure | Phase 2 | France | - | |
| Heart Failure | Phase 2 | United Kingdom | - | - |
| Hypertension | Phase 2 | France | - | |
| Hypertension | Phase 2 | United Kingdom | - | - |





